PSYCHIATRY & BEHAVIOURAL SCIENCES

We are dedicated to advancing mental health care through comprehensive and ethical clinical research in psychiatry and behavioural sciences. Mental health disorders affect millions globally, with profound impacts on quality of life, productivity, and overall well-being. Our research is focused on developing safe, effective, and innovative therapies for a wide range of psychiatric and neurobehavioral conditions.

With a patient-centric approach, we collaborate closely with psychiatrists, psychologists, neurologists, and behavioral scientists to conduct studies that adhere to the highest standards of clinical and ethical excellence.

psychiatry

Core Areas of Focus:

  • Mood Disorders

    • – Major Depressive Disorder (MDD)

    – Bipolar Disorder (Type I & II)

  • Anxiety Disorders

    • – Generalized Anxiety Disorder (GAD)

    – Panic Disorder, Social Anxiety, PTSD

  • Psychotic Disorders

    • – Schizophrenia and Schizoaffective Disorder

  • Neurodevelopmental Disorders

    • – Autism Spectrum Disorder (ASD)

    – Attention Deficit Hyperactivity Disorder (ADHD)

  • Neurocognitive and Degenerative Disorders

    • – Alzheimer’s Disease, Mild Cognitive Impairment

    – Dementia with Behavioral Symptoms

  • Addiction and Substance Use Disorders

    • – Alcohol, nicotine, and opioid dependence

  • Sleep and Eating Disorders

    • – Insomnia, circadian rhythm disorders

    – Anorexia nervosa, bulimia, binge-eating disorder

Research Capabilities at Tupalin Research:

  • Specialized psychiatric and behavioral health sites with access to inpatient and outpatient populations
  • Validated psychometric tools and clinician-administered rating scales (e.g., HAM-D, MADRS, PANSS, CGI, ADOS)
  • Central Laboratory Services for neuroendocrine, pharmacokinetic, and biomarker testing
  • Electronic Data Capture (EDC) tailored for longitudinal, symptom-based data
  • IVRS/IWRS Systems for subject randomization, blinding, and dose titration
  • CTMS for robust trial oversight and real-time monitoring
  • Telepsychiatry-enabled platforms for hybrid and decentralized trial models

Our Commitment:

We recognize the complexity and sensitivity of psychiatric research. Our studies are designed with compassion, confidentiality, and clinical rigor to support the development of transformative treatments. We strive to reduce stigma and improve access to care through evidence-based solutions that address the diverse needs of patients across the mental health spectrum.

Together with our partners and sponsors, we are redefining what’s possible in mental health research—building a future where better outcomes and hope go hand in hand.